Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Neurofibromin 1 | 4 | 2021 | 190 | 1.290 |
Why?
|
Zebrafish | 25 | 2021 | 3036 | 0.980 |
Why?
|
Neuroblastoma | 5 | 2018 | 1266 | 0.620 |
Why?
|
Thiophenes | 2 | 2021 | 570 | 0.580 |
Why?
|
PTEN Phosphohydrolase | 1 | 2021 | 1119 | 0.500 |
Why?
|
Sulfonamides | 2 | 2021 | 1982 | 0.400 |
Why?
|
Xenograft Model Antitumor Assays | 3 | 2021 | 3608 | 0.390 |
Why?
|
Liver Neoplasms, Experimental | 1 | 2011 | 189 | 0.350 |
Why?
|
Zebrafish Proteins | 8 | 2018 | 1019 | 0.340 |
Why?
|
Pyrimidines | 2 | 2021 | 3044 | 0.330 |
Why?
|
Receptors, Vascular Endothelial Growth Factor | 1 | 2012 | 661 | 0.310 |
Why?
|
Embryo, Nonmammalian | 7 | 2018 | 910 | 0.310 |
Why?
|
Neural Stem Cells | 1 | 2016 | 895 | 0.310 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 2 | 2016 | 1761 | 0.310 |
Why?
|
Neoplasm Metastasis | 4 | 2017 | 4892 | 0.270 |
Why?
|
Melanoma | 3 | 2021 | 5702 | 0.260 |
Why?
|
Drug Synergism | 2 | 2021 | 1759 | 0.250 |
Why?
|
Disease Models, Animal | 9 | 2018 | 18330 | 0.230 |
Why?
|
Gene Expression | 2 | 2016 | 7587 | 0.220 |
Why?
|
Cell Transformation, Neoplastic | 4 | 2016 | 2843 | 0.220 |
Why?
|
Neoplasm Transplantation | 4 | 2018 | 2012 | 0.200 |
Why?
|
Signal Transduction | 8 | 2017 | 23621 | 0.170 |
Why?
|
Neutrophils | 1 | 2012 | 3779 | 0.160 |
Why?
|
Cell Survival | 3 | 2021 | 5750 | 0.160 |
Why?
|
Carcinoma, Hepatocellular | 1 | 2011 | 2330 | 0.150 |
Why?
|
Cell Proliferation | 6 | 2021 | 10455 | 0.140 |
Why?
|
Mitogen-Activated Protein Kinase 3 | 2 | 2008 | 474 | 0.130 |
Why?
|
Embryonic Development | 3 | 2012 | 722 | 0.130 |
Why?
|
Mitogen-Activated Protein Kinase 1 | 2 | 2008 | 478 | 0.130 |
Why?
|
Animals, Genetically Modified | 6 | 2017 | 1562 | 0.130 |
Why?
|
Protein Tyrosine Phosphatase, Non-Receptor Type 11 | 1 | 2017 | 224 | 0.130 |
Why?
|
Cell Line, Tumor | 8 | 2021 | 17097 | 0.130 |
Why?
|
Proto-Oncogene Proteins c-myc | 2 | 2018 | 998 | 0.120 |
Why?
|
Animals | 26 | 2021 | 168965 | 0.120 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 1 | 2021 | 1405 | 0.120 |
Why?
|
Cell Tracking | 1 | 2016 | 139 | 0.120 |
Why?
|
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2018 | 384 | 0.120 |
Why?
|
Receptor, Platelet-Derived Growth Factor alpha | 1 | 2016 | 367 | 0.120 |
Why?
|
Enhancer Elements, Genetic | 2 | 2018 | 1366 | 0.110 |
Why?
|
Nerve Sheath Neoplasms | 1 | 2016 | 169 | 0.110 |
Why?
|
Sirolimus | 1 | 2021 | 1539 | 0.110 |
Why?
|
Gene Expression Regulation, Neoplastic | 4 | 2018 | 8628 | 0.100 |
Why?
|
Cell Movement | 4 | 2017 | 5203 | 0.100 |
Why?
|
Beclomethasone | 1 | 2012 | 38 | 0.100 |
Why?
|
Oncogenes | 1 | 2018 | 1232 | 0.100 |
Why?
|
Phosphorylase Kinase | 1 | 2011 | 10 | 0.100 |
Why?
|
Dioxygenases | 1 | 2014 | 353 | 0.100 |
Why?
|
Genes, Neurofibromatosis 1 | 1 | 2012 | 75 | 0.100 |
Why?
|
Tumor Cells, Cultured | 3 | 2018 | 6106 | 0.100 |
Why?
|
9,10-Dimethyl-1,2-benzanthracene | 1 | 2011 | 58 | 0.100 |
Why?
|
Neurilemmoma | 1 | 2016 | 522 | 0.090 |
Why?
|
Proto-Oncogene Proteins c-raf | 1 | 2011 | 205 | 0.090 |
Why?
|
MAP Kinase Signaling System | 3 | 2017 | 1492 | 0.090 |
Why?
|
Extracellular Matrix | 2 | 2017 | 1733 | 0.090 |
Why?
|
Transplantation, Heterologous | 3 | 2016 | 2391 | 0.080 |
Why?
|
Repressor Proteins | 2 | 2018 | 2979 | 0.080 |
Why?
|
Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2018 | 1559 | 0.080 |
Why?
|
Carcinogens | 1 | 2011 | 452 | 0.080 |
Why?
|
Transforming Growth Factor beta | 2 | 2014 | 1995 | 0.080 |
Why?
|
Gene Amplification | 3 | 2018 | 1088 | 0.080 |
Why?
|
Tumor Suppressor Protein p53 | 2 | 2016 | 2952 | 0.080 |
Why?
|
Gastrula | 1 | 2008 | 83 | 0.070 |
Why?
|
Myeloid Cells | 1 | 2012 | 837 | 0.070 |
Why?
|
Neurofibromatosis 1 | 1 | 2012 | 561 | 0.070 |
Why?
|
DNA-Binding Proteins | 4 | 2017 | 9612 | 0.070 |
Why?
|
Tamoxifen | 1 | 2011 | 966 | 0.070 |
Why?
|
Pyrroles | 1 | 2012 | 1122 | 0.060 |
Why?
|
Protein-Tyrosine Kinases | 1 | 2014 | 2428 | 0.060 |
Why?
|
Myelodysplastic Syndromes | 1 | 2014 | 1399 | 0.060 |
Why?
|
Transcription, Genetic | 1 | 2018 | 7611 | 0.060 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2014 | 2887 | 0.060 |
Why?
|
Multigene Family | 2 | 2006 | 1081 | 0.060 |
Why?
|
Molecular Targeted Therapy | 2 | 2014 | 2824 | 0.060 |
Why?
|
Indoles | 1 | 2012 | 1836 | 0.060 |
Why?
|
Carrier Proteins | 1 | 2017 | 4925 | 0.060 |
Why?
|
Gene Expression Profiling | 4 | 2017 | 9532 | 0.050 |
Why?
|
Endothelial Cells | 2 | 2012 | 3582 | 0.050 |
Why?
|
Hyperplasia | 2 | 2017 | 1150 | 0.050 |
Why?
|
Angiogenesis Inhibitors | 1 | 2011 | 2055 | 0.050 |
Why?
|
Neovascularization, Pathologic | 1 | 2011 | 2627 | 0.050 |
Why?
|
Mitogen-Activated Protein Kinases | 1 | 2006 | 1244 | 0.050 |
Why?
|
Transcription Factors | 2 | 2018 | 12158 | 0.050 |
Why?
|
Mice | 7 | 2018 | 81912 | 0.050 |
Why?
|
T-Lymphocytes | 1 | 2018 | 10254 | 0.040 |
Why?
|
Mice, Nude | 2 | 2018 | 3618 | 0.040 |
Why?
|
Humans | 18 | 2021 | 767040 | 0.040 |
Why?
|
Gene Expression Regulation, Developmental | 2 | 2008 | 3610 | 0.040 |
Why?
|
Protein Kinase Inhibitors | 1 | 2014 | 5693 | 0.040 |
Why?
|
Diagnostic Imaging | 1 | 2012 | 3530 | 0.040 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2018 | 11872 | 0.040 |
Why?
|
Breast Neoplasms | 3 | 2013 | 21178 | 0.030 |
Why?
|
Response Elements | 1 | 2018 | 308 | 0.030 |
Why?
|
Gene Expression Regulation | 1 | 2014 | 11923 | 0.030 |
Why?
|
Neoplasms | 3 | 2016 | 22350 | 0.030 |
Why?
|
Mutagenesis, Insertional | 1 | 2018 | 661 | 0.030 |
Why?
|
Carbazoles | 1 | 2017 | 230 | 0.030 |
Why?
|
Luminescent Proteins | 1 | 2017 | 839 | 0.030 |
Why?
|
RNA, Small Interfering | 2 | 2014 | 3427 | 0.030 |
Why?
|
Gene Expression Regulation, Leukemic | 1 | 2018 | 658 | 0.030 |
Why?
|
Prostatic Neoplasms | 2 | 2014 | 11097 | 0.030 |
Why?
|
Base Sequence | 2 | 2018 | 12414 | 0.030 |
Why?
|
Receptors, Cell Surface | 1 | 2004 | 2815 | 0.030 |
Why?
|
Rodentia | 1 | 2016 | 262 | 0.030 |
Why?
|
Transgenes | 1 | 2017 | 1014 | 0.030 |
Why?
|
Flow Cytometry | 2 | 2014 | 5891 | 0.030 |
Why?
|
Chromones | 1 | 2013 | 148 | 0.030 |
Why?
|
Dioxoles | 1 | 2013 | 96 | 0.030 |
Why?
|
Smad2 Protein | 1 | 2013 | 144 | 0.030 |
Why?
|
Membrane Glycoproteins | 1 | 2004 | 3702 | 0.030 |
Why?
|
Time-Lapse Imaging | 1 | 2014 | 194 | 0.030 |
Why?
|
Up-Regulation | 2 | 2012 | 4143 | 0.030 |
Why?
|
Melanophores | 1 | 2012 | 16 | 0.030 |
Why?
|
Smad4 Protein | 1 | 2013 | 193 | 0.030 |
Why?
|
Neoplasms, Experimental | 1 | 2017 | 1228 | 0.030 |
Why?
|
Catalytic Domain | 1 | 2014 | 699 | 0.030 |
Why?
|
Receptors, Transforming Growth Factor beta | 1 | 2013 | 304 | 0.020 |
Why?
|
Luciferases | 1 | 2014 | 713 | 0.020 |
Why?
|
Translocation, Genetic | 1 | 2017 | 1391 | 0.020 |
Why?
|
Dipeptides | 1 | 2013 | 386 | 0.020 |
Why?
|
Apoptosis | 2 | 2018 | 9513 | 0.020 |
Why?
|
Schwann Cells | 1 | 2012 | 195 | 0.020 |
Why?
|
Drug Screening Assays, Antitumor | 1 | 2013 | 719 | 0.020 |
Why?
|
Down-Regulation | 1 | 2018 | 2931 | 0.020 |
Why?
|
In Situ Hybridization | 1 | 2014 | 1892 | 0.020 |
Why?
|
Dexamethasone | 1 | 2018 | 1963 | 0.020 |
Why?
|
Stem Cells | 2 | 2014 | 3535 | 0.020 |
Why?
|
Larva | 1 | 2012 | 512 | 0.020 |
Why?
|
Morpholines | 1 | 2013 | 584 | 0.020 |
Why?
|
Immunocompromised Host | 1 | 2016 | 862 | 0.020 |
Why?
|
CpG Islands | 1 | 2014 | 1206 | 0.020 |
Why?
|
Lung Neoplasms | 1 | 2014 | 13491 | 0.020 |
Why?
|
Neoplasm Invasiveness | 1 | 2017 | 3611 | 0.020 |
Why?
|
Cadherins | 1 | 2014 | 903 | 0.020 |
Why?
|
Microarray Analysis | 1 | 2012 | 751 | 0.020 |
Why?
|
Glucocorticoids | 1 | 2018 | 2163 | 0.020 |
Why?
|
Oligodendroglia | 1 | 2012 | 539 | 0.020 |
Why?
|
Myelin Sheath | 1 | 2012 | 649 | 0.020 |
Why?
|
Small Molecule Libraries | 1 | 2013 | 742 | 0.020 |
Why?
|
Benzamides | 1 | 2013 | 1376 | 0.020 |
Why?
|
Amino Acid Sequence | 2 | 2012 | 13411 | 0.020 |
Why?
|
Immunohistochemistry | 2 | 2014 | 11063 | 0.020 |
Why?
|
Gene Silencing | 1 | 2014 | 1505 | 0.020 |
Why?
|
Endoderm | 1 | 2008 | 165 | 0.020 |
Why?
|
Phylogeny | 2 | 2006 | 2840 | 0.020 |
Why?
|
Gene Dosage | 1 | 2011 | 1211 | 0.020 |
Why?
|
ras Proteins | 1 | 2012 | 1054 | 0.020 |
Why?
|
Molecular Sequence Data | 2 | 2012 | 17608 | 0.020 |
Why?
|
Drug Evaluation, Preclinical | 1 | 2011 | 1331 | 0.020 |
Why?
|
Blotting, Western | 1 | 2014 | 5022 | 0.020 |
Why?
|
Mutation | 3 | 2017 | 30211 | 0.020 |
Why?
|
Protein Binding | 1 | 2018 | 9327 | 0.020 |
Why?
|
High-Throughput Screening Assays | 1 | 2011 | 940 | 0.020 |
Why?
|
Mice, Inbred BALB C | 1 | 2014 | 6226 | 0.020 |
Why?
|
Hematopoiesis | 1 | 2014 | 2056 | 0.020 |
Why?
|
HEK293 Cells | 1 | 2014 | 4280 | 0.020 |
Why?
|
Survival Analysis | 1 | 2017 | 10092 | 0.020 |
Why?
|
Mesoderm | 1 | 2008 | 679 | 0.010 |
Why?
|
Green Fluorescent Proteins | 1 | 2010 | 2063 | 0.010 |
Why?
|
Homeodomain Proteins | 1 | 2014 | 2429 | 0.010 |
Why?
|
Receptors, Interleukin-18 | 1 | 2004 | 25 | 0.010 |
Why?
|
Morphogenesis | 1 | 2008 | 746 | 0.010 |
Why?
|
Interleukin-18 Receptor alpha Subunit | 1 | 2004 | 18 | 0.010 |
Why?
|
Toll-Like Receptor 1 | 1 | 2004 | 48 | 0.010 |
Why?
|
Toll-Like Receptor 5 | 1 | 2004 | 42 | 0.010 |
Why?
|
Drug Discovery | 1 | 2012 | 1068 | 0.010 |
Why?
|
Sequence Homology | 1 | 2004 | 197 | 0.010 |
Why?
|
Toll-Like Receptor 3 | 1 | 2004 | 98 | 0.010 |
Why?
|
Toll-Like Receptor 8 | 1 | 2004 | 98 | 0.010 |
Why?
|
Enzyme Inhibitors | 1 | 2013 | 3726 | 0.010 |
Why?
|
Receptors, Interleukin-1 | 1 | 2004 | 260 | 0.010 |
Why?
|
Learning | 1 | 2012 | 1754 | 0.010 |
Why?
|
Receptors, Interleukin | 1 | 2004 | 243 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 1 | 2010 | 36582 | 0.010 |
Why?
|
Sequence Analysis, Protein | 1 | 2004 | 261 | 0.010 |
Why?
|
Toll-Like Receptor 7 | 1 | 2004 | 169 | 0.010 |
Why?
|
Hematopoietic Stem Cells | 1 | 2014 | 3408 | 0.010 |
Why?
|
Motor Activity | 1 | 2012 | 2713 | 0.010 |
Why?
|
Fibroblast Growth Factors | 1 | 2008 | 873 | 0.010 |
Why?
|
Sequence Homology, Amino Acid | 1 | 2006 | 2745 | 0.010 |
Why?
|
Toll-Like Receptor 2 | 1 | 2004 | 348 | 0.010 |
Why?
|
Models, Biological | 1 | 2017 | 9464 | 0.010 |
Why?
|
Cloning, Molecular | 1 | 2006 | 4167 | 0.010 |
Why?
|
Toll-Like Receptors | 1 | 2004 | 582 | 0.010 |
Why?
|
Toll-Like Receptor 4 | 1 | 2004 | 588 | 0.010 |
Why?
|
Genotype | 1 | 2014 | 13035 | 0.010 |
Why?
|
Sequence Alignment | 1 | 2004 | 2176 | 0.010 |
Why?
|
Kidney | 1 | 2014 | 7063 | 0.010 |
Why?
|
Disease Progression | 1 | 2016 | 13646 | 0.010 |
Why?
|
Mice, Knockout | 1 | 2014 | 14476 | 0.010 |
Why?
|
MicroRNAs | 1 | 2014 | 3792 | 0.010 |
Why?
|
Cell Line | 1 | 2011 | 15567 | 0.010 |
Why?
|
Cell Differentiation | 1 | 2014 | 11657 | 0.010 |
Why?
|
Protein Structure, Tertiary | 1 | 2004 | 3760 | 0.010 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2004 | 4572 | 0.010 |
Why?
|
Infant | 1 | 2018 | 36485 | 0.010 |
Why?
|
Child, Preschool | 1 | 2018 | 42606 | 0.010 |
Why?
|
Sequence Analysis, DNA | 1 | 2004 | 4780 | 0.010 |
Why?
|
Colorectal Neoplasms | 1 | 2012 | 6966 | 0.010 |
Why?
|
Female | 3 | 2018 | 396660 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2018 | 65295 | 0.010 |
Why?
|
Risk Factors | 1 | 2017 | 74886 | 0.010 |
Why?
|
Child | 1 | 2017 | 80771 | 0.010 |
Why?
|
Male | 2 | 2014 | 364203 | 0.000 |
Why?
|